Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Actio Biosciences
AddedFeb 17, 2024
UpdatedJun 18, 2026
Actio Biosciences

Actio Biosciences

Developing precision medicine through genetics for rare and common diseases, streamlining drug discovery and development.

HQ
San Diego, CA, US
Founded
2021
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to revolutionize precision medicine, Actio Biosciences focuses on developing therapeutics that target the shared underlying biology of both rare and common diseases. Leveraging advances in genetics, drug discovery, and data sciences, the company aims to streamline the drug development process and bring forward potent, precisely targeted treatments. Actio Biosciences is dedicated to identifying programs where biological and technical risks can be minimized, ensuring the efficient development of meaningful medicines.

Actio Biosciences boasts a team of experts in genetics and drug discovery, supported by notable investors committed to advancing precision medicine. The company's innovative approach has led to significant achievements in identifying promising therapeutic targets that address high unmet medical needs. By bridging the gap between rare and common diseases, Actio Biosciences is making a substantial impact on the healthcare landscape, offering new hope for patients through its cutting-edge treatments.

Actio Biosciences - Similar Companies

Cogent Biosciences logo

Cogent Biosciences

cogentbio.com

Variant Bio logo

Variant Bio

variantbio.com

Empirico logo

Empirico

empiricotx.com

BridGene Biosciences logo

BridGene Biosciences

Actuate Therapeutics logo

Actuate Therapeutics

Apic Bio logo

Apic Bio

Nested Therapeutics logo

Nested Therapeutics

nestedtx.com

ACT Biotech logo

ACT Biotech

Akttyva Therapeutics logo

Akttyva Therapeutics

akttyva.com

Curie.Bio logo

Curie.Bio

curie.bio

HI-Bio logo

HI-Bio

hibio.com

Judo Bio logo

Judo Bio

Encoded Therapeutics logo

Encoded Therapeutics

1910 logo

1910

1910genetics.com

Reactive Biosciences logo

Reactive Biosciences

reactivebio.com

Actio Biosciences - Quick Facts

Who are Actio Biosciences' competitors?

Companies similar to Actio Biosciences include Cogent Biosciences, Variant Bio, Empirico and BridGene Biosciences.

When was Actio Biosciences founded?

Actio Biosciences was founded in 2021.

Where is Actio Biosciences' headquarters located?

Actio Biosciences' headquarters is located in San Diego, CA, US.

When was Actio Biosciences' last funding round?

Actio Biosciences' most recent funding round was for $55M (USD) in September 2023.

How much has Actio Biosciences raised to-date?

As of Sep 12, 2023, Actio Biosciences has raised a total of $55M (USD).

How many employees does Actio Biosciences have?

Actio Biosciences has 22 employees as of Feb 4, 2024.

Actio Biosciences - Classification

Industry
  • Therapeutics
Ownership
  • Private
  • Venture Capital
Technology
  • AI
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Therapeutics
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software